Life Science REIT (LABS) Stock Forecast & Price Target

GBX 37

+2.80 (+8.19%)

(As of 09/27/2024 ET)

Life Science REIT - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 3 Analyst Ratings

Sell
0

Hold
1

Buy
2

Based on 3 Wall Street analysts who have issued ratings for Life Science REIT in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for LABS.

Consensus Price Target

GBX 57.50

According to the 3 analysts' twelve-month price targets for Life Science REIT, the average price target is GBX 57.50. The highest price target for LABS is GBX 79, while the lowest price target for LABS is GBX 36. The average price target represents a forecasted upside of 55.41% from the current price of GBX 37.

Get the Latest News and Ratings for LABS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Life Science REIT and its competitors.

LABS Analyst Ratings Over Time

Type	Current Forecast 9/28/23 to 9/27/24	1 Month Ago 8/29/23 to 8/28/24	3 Months Ago 6/30/23 to 6/29/24	1 Year Ago 9/28/22 to 9/28/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)
Hold	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	GBX 57.50	GBX 79	GBX 79	GBX 114
Consensus Rating	Moderate Buy	Buy	Buy	Buy

Protect Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

LABS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

LABS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Life Science REIT Stock vs. The Competition

Type	Life Science REIT	Companies
Consensus Rating Score	2.67	3.09
Consensus Rating	Moderate Buy	Buy
News Sentiment Rating	Neutral News See Recent LABS News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
9/26/2024	Shore Capital 1 of 5 stars	Reiterated Rating	Buy
8/30/2024	Jefferies Financial Group 2 of 5 stars	Lower Target	Hold	GBX 45 ➝ GBX 36	+6.04%
2/9/2024	Berenberg Bank 2 of 5 stars	Reiterated Rating	Buy	GBX 79	+52.51%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 06:56 PM ET.

LABS Forecast - Frequently Asked Questions

: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Life Science REIT is GBX 57.50, with a high forecast of GBX 79 and a low forecast of GBX 36.
: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Life Science REIT in the last year. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" LABS shares.
: According to analysts, Life Science REIT's stock has a predicted upside of 55.41% based on their 12-month stock forecasts.
: Life Science REIT has been rated by research analysts at Jefferies Financial Group, and Shore Capital in the past 90 days.
: Analysts like Life Science REIT less than other "" companies. The consensus rating for Life Science REIT is Moderate Buy while the average consensus rating for "" companies is Buy. Learn more on how LABS compares to other companies.

Stock Forecasts and Research Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)

The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.

Take these 4 steps today to protect your retirement NOW

This page (LON:LABS) was last updated on 9/27/2024 by MarketBeat.com Staff

From Our Partners